Vidyashankara G. Iyer
Molecular Biology · 2008–2021
A researcher in the Science corpus: 3 papers; trusts 1 researcher and is trusted by 2 researchers here, as inferred from the citation graph.
Subfields
- Molecular Biology — 21 citations into it; #13,654 of 17,773 by trust here, #9,270 by citations
Whom Vidyashankara G. Iyer trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts Vidyashankara G. Iyer overall
Papers from Vidyashankara G. Iyer's perspective
Ordered by how strongly the researchers Vidyashankara G. Iyer trusts endorse each paper. Same corpus, a different order for every researcher.
- Computational Biochemistry and Biophysics
- Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
- Scalable Algorithms for Molecular Dynamics Simulations on Commodity Clusters (International Conference on Software Composition)
- VMD: visual molecular dynamics.
- Automation of the CHARMM General Force Field (CGenFF) I: Bond Perception and Atom Typing (Journal of Chemical Information and Modeling)
- Proteins: Structures and Molecular Properties
- The Protein Data Bank: a computer-based archival file for macromolecular structures.
- Statistically optimal analysis of samples from multiple equilibrium states. (Journal of Chemical Physics)
- Recent advances in structure-based rational drug design.
- A Second Generation Force Field for the Simulation of Proteins, Nucleic Acids, and Organic Molecules J. Am. Chem. Soc. 1995, 117, 5179−5197
Their papers
- CHARMM‐GUI: A web‐based graphical user interface for CHARMM (2008) — 8,238 citations
- Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials (2021) — 1,053 citations
- Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK (2020) — 4,032 citations